Background
Cardiovascular disorders associated with endothelial dysfunction, such as atherosclerosis, have decreased nitric oxide (NO) bioavailability. Arginase in the vasculature can compete with eNOS for L-arginine and has been implicated in atherosclerosis. The
Conclusion
We conclude that overexpression of arginase II in the endothelium is detrimental to the cardiovascular system.
